Vaccine Analysis

Added: Jun 13, 2016 1:47 pm
The Centers for Disease Control and Prevention, NCIRD/ISD, 1600 Clifton Rd. NE, Mailstop A19, Atlanta, GA, 30333, hereby announces its intent to issue a sole source contract to The Regents of The University of Colorado 10331 E 17th Place F428 Aurora, Colorado to collect and analyze 600 herpes zoster vaccine samples from the Centers for Disease Control and Prevention.

NAICS Code: 541711

Period of Performance: 07/01/2016 to 05/31/2017

The statutory authority permitting other than full and open competition is 41 U.S.C. 253(c)(1) as cited in FAR 13.106-1(b)(1)(i). The University of Colorado is part of an ongoing collaboration with the Centers for Disease Control and Prevention in researching the Herpes Zoster vaccines of both Merck and GSK. Market research has provided no other company/institution that could identify the necessary donors, collect the needed amount of serum, and process the samples in time to complete the project by 05/31/2017.

Responsible sources that believe they possess the expertise and capabilities identified above are encouraged to submit to the Contracting Officer within 15 days from the posting date of this notice, their written capabilities statement, proposal or quotation which shall be considered by the agency for future procurement. Please forward the capability statement and/or pricing information to Michael Harwell, Contracting Specialist, Reference 200-2013-M-54126, Centers for Disease Control, Procurement and Grants Office, ATTN: Michael Harwell, MS: K14, 2920 Brandywine Road, Atlanta, GA 30341. All vendors must be registered in the System for Award Management (SAM) prior to an award of a federal contract. The website is: www.sam.gov.

This is a posting of a sole source award to The Regents of The University of Colorado and is not a request for competition.